13F Filings History of Sanofi

Latest 13F report
Q4 2025 - 11 Feb 2026
Value $
$310,414,825
Signature - Title
Alexandra Roger - Head of Legal Corporate & Finance
Location
Paris, France
Summary
This page shows a list of all the recent 13F filings made by Sanofi. Form 13F is required to be filed within 45 days of the end of a calendar quarter. Sanofi reported 8 stock holdings with total value $310,414,825 as of Q4 2025. Top holdings included MGTX, INBX, NVAX, ANAB, and IMRX.

Notify me when Sanofi files a new 13F portfolio report.

⭐ Subscribe ⭐
Holdings Value
Quarter Holdings Value $ Bought Sold Net Top Holdings Form Type Filing Time
Q4 2025 8 $310,414,825 +$16,020,000 -$14,599,955 +$1,420,045 MGTX, INBX, NVAX, ANAB, IMRX 13F-HR 11 Feb 2026, 08:47
Q3 2025 9 $260,361,143 +$18,959,913 -$3,384,672 +$15,575,241 MGTX, NVAX, INBX, ANAB, IMRX 13F-HR 04 Nov 2025, 10:51
Q2 2025 10 $175,742,794 +$9,605,725 $0 +$9,605,725 MGTX, NVAX, ANAB, INBX, OMDA 13F-HR 29 Jul 2025, 12:18
Q1 2025 9 $165,944,772 $0 $0 $0 MGTX, NVAX, INBX, ANAB, ELDN 13F-HR 06 May 2025, 06:15
Q4 2024 9 $174,360,245 $0 $0 $0 MGTX, NVAX, INBX, ANAB, IGMS 13F-HR 14 Feb 2025, 11:28